NEWSROOM

NASDAQ

AmpliTech Group Announces New Product Lines; Adds E-Commerce Capabilities to Website

AmpliTech Group Announces New Product Lines; Adds E-Commerce Capabilities to Website

Nov 2, 2023

HAUPPAUGE, NY, November 2, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks and a worldwide distributor of packages and lids for integrated circuit assembly, and designer of complete 5G/6G systems, is proud to introduce its latest new product offerings, which include Low Noise Amplifiers, Coaxial In-Line LNAs, and Coaxial In-Line Band Pass Filters from...

PRISM MarketView Oil & Gas Index Update: WTI Crude Reverses Gains, Earnings Season in Full Swing

Nov 1, 2023

NEW YORK, NY, November 1, 2023 - PRISM MarketView, a leading provider of market insight and company news, today provides its PRISM Emerging Oil & Gas overview. US equities finished mostly higher in Wednesday afternoon trading, near best levels. The S&P 500 Energy Index closed down (0.33%) versus the S&P 500 which was up +1.05%, the XLE declined by (0.23%) and the XOP was down (0.19%). Today’s PRISM Oil & Gas Index update saw WTI crude ending down 0.7%, reversing earlier gains,...

PRISM MARKETVIEW’S EMERGING HEALTHCARE INDEX HIGHLIGHTS LIFEMD, INC. AS ITS LARGEST YTD GAINER, UP ~226%

Nov 1, 2023

NEW YORK, NY, November 1, 2023 - LifeMD, Inc. is the current YTD leader in the PRISM Emerging Healthcare Index. The company has seen a ~226% increase this year and is trading at approximately $6 per share. This price falls on the higher end of its 52-week range of $1.14 – $7.40 which may indicate the potential for continued growth in a potentially shorter time frame. The company’s market cap is $227MM with a 3-month average trading volume of 500K shares. ...

AmpliTech Group’s Division, AGMDC (AmpliTech Group Microwave Design Center), Inks Distribution Deal with Component Distributors Inc (CDI), a Global Value-Added Distributor of Electronic Components

AmpliTech Group’s Division, AGMDC (AmpliTech Group Microwave Design Center), Inks Distribution Deal with Component Distributors Inc (CDI), a Global Value-Added Distributor of Electronic Components

Nov 1, 2023

HAUPPAUGE, NY, November 1, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks and a worldwide distributor of packages and lids for integrated circuit assembly, and designer of complete 5G/6G systems, is proud to announce it has entered an agreement with Component Distributors Inc, (CDI), a well-established electronic components distributor. CDI will market and...

PRISM MarketView Highlights Its Spooktacular Zombie Index For Halloween

Oct 30, 2023

NEW YORK, NY, October 30, 2023 - Halloween is the time of year where everyone has the chance to wear a costume and enjoy some spooky activities to celebrate the season such as indulging in a pumpkin flavored treat or visiting a haunted house. If you are still uncertain about what costume to wear, we are here to guide you with some timely costume ideas. For those who are looking for some thoughtful disguises and investment insights, we will be highlighting a series of Zombie stocks that are...

PRISM MediaWire – Weekly Press Resume – Oct. 23 to Oct. 27, 2023

PRISM MediaWire – Weekly Press Resume – Oct. 23 to Oct. 27, 2023

Oct 27, 2023

New York, New York, October 27, 2023 PRISM MediaWire - Weekly Press Resume Oct. 23 to Oct. 27, 2023 Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference https://prismmediawire.com/lipella-pharmaceuticals-to-present-at-the-fall-foliage-microcap-rodeo-conference/ Metatron Partners with MML Marketing, Boasting a Proven Track Record of $19M in Sales https://prismmediawire.com/metatron-partners-with-mml-marketing-boasting-a-proven-track-record-of-19m-in-sales/ Argentum...

10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis

Oct 24, 2023

NEW YORK, NY, October 24, 2023 - The biotech sector, known for its exponential growth potential, is currently facing highly challenging market conditions. Influences like rising inflation, geopolitical tensions, and looming economic recessions have led to a sharp decline in the sector. Consequently, many small and micro-cap biotech companies are trading at all-time lows, with several down by over 80-90% in recent years. This downturn has led to many biotech firms trading below their cash...

SELLAS Advances Blood Cancer Treatment with “Tremendous Therapeutic Promise”

Oct 11, 2023

October 11, 2023 SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) has reported two significant milestones this week as it pursues development of its drug candidate, SLS009 for hematological malignancies. “SLS009 is a novel and highly selective CDK9 inhibitor which, to date, has shown tremendous therapeutic promise across multiple blood cancers.” Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS The company has dosed the first patient in a Phase Ib/II trial...

PRISM MarketView Launches Mental Health Index on World Mental Health Day

Oct 11, 2023

Index Highlights Innovative Companies Addressing the Unseen Challenges of Mental Disorders New York City, October 11, 2023 - In honor of World Mental Health Day, which raises awareness of mental health issues on a global scale, PRISM MarketView has introduced the Prism Emerging Mental Health Index, a proprietary index focused on pioneering stocks offering innovative treatments for mood issues, anxiety, personality disorders and more....

AmpliTech CEO Fawad Maqbool to Deliver Fireside Chat at Maxim Group’s TMT Conference

AmpliTech CEO Fawad Maqbool to Deliver Fireside Chat at Maxim Group’s TMT Conference

Oct 9, 2023

Virtual Presentation on Wednesday, October 11th at 4:00 pm ET HAUPPAUGE, NY, October 9, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, as well as a worldwide distributor of packages and lids for integrated circuit assembly, today announced that Chief Executive Officer Fawad Maqbool will be delivering a fireside chat at Maxim Group’s Virtual TMT...

AmpliTech CEO Fawad Maqbool to Deliver Fireside Chat at Maxim Group’s TMT Conference

AmpliTech’s Satcom Systems Subdivision Receives Orders from Major Media Companies

Oct 4, 2023

Specialty Microwave Subdivision Achieves a Record $1mm Bookings for 2023 HAUPPAUGE, NY, October 4, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, as well as a worldwide distributor of packages and lids for integrated circuit assembly, is thrilled to announce new partnerships and an uptick in bookings within its Satcom components subdivision, Specialty...

SKYX to Significantly Expand Market Penetration with QUOIZEL Collaboration

Sep 28, 2023

“In my 32 years in the lighting business. It is by far the most disruptive technology I have seen and will transform the lighting industry from the old existing hardwire installation method to a safe plug-and-play installation method.” Rick Seidman, Chief Executive Officer of QUOIZEL September 28, 2023 Disruptive platform technology company, SKYX (Nasdaq: SKYX) will significantly increase its market penetration through a new collaboration with QUOIZEL, a U.S. leading lighting supplier and...

SELLAS SLS009 Phase 1 Clinical Study Successfully Achieves All Primary and Secondary Endpoints

Sep 22, 2023

September 22, 2023 Late-stage biopharmaceutical company, SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) has announced positive topline data for the patient group with relapsed/refractory (r/r) lymphomas from its Phase 1 dose-escalation trial of its CDK9 inhibitor, SLS009 (GFH009). We are excited to share strong topline data from the Phase 1 trial of SLS009 in lymphoma patients. The data demonstrate meaningful anti-tumor activity and clinical responses as a monotherapy. Based on its...

SKYX Platforms (SKYX) Increases Patent Count With Five Additional Issued in US and International

Sep 22, 2023

September 22, 2023 Today SKYX Platforms (SKYX) has announced the issuance of five new utility patents in the U.S. and international markets including Canada, Mexico and Hong Kong for its related smart plug-and-play products including a ceiling fan with a heater and recessed light. The company now has 77 issued and pending patents, globally. https://prismmarketview.com/skyx-platforms-skyx-increases-patent-count-with-five-additional-issued-in-us-and-international/ Recent...

SKYX Appoints Widely-Respected Public Financial Markets Authority, Lenny Sokolow as Co-CEO

Sep 19, 2023

"I can't emphasize enough how excited I am to join SKYX and introduce its growth opportunity to the financial institution segments during its inflection point. As evidence, I agreed for the majority of my compensation to be paid in SKYX's stock and stock options.” Leonard (Lenny) Sokolow “Growth Opportunity at Key Inflection Point” HIGHLIGHTS SKYX Platforms (Nasdaq: SKYX) has appointed Mr. Lenny Sokolow to the position of co-CEO. This week, SKYX also filed for a mandatory safety...

Oncocyte’s VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier

Sep 18, 2023

Interventional study compares VitaGraft to current transplant rejection monitoring protocols Oncocyte’s VitaGraft assay detects antibody-mediated transplant rejection 10 months sooner than commonly used monitoring protocols (p<0.001) IRVINE, CA, September 18, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced the presentation of significant new clinical data at the European Society of Organ Transplant (ESOT) conference. The data was generated from a...

AmpliTech to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

AmpliTech to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

Sep 8, 2023

CEO Fawad Maqbool will be meeting with registered investors on September 11-12, 2023 HAUPPAUGE, NY, September 8, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, today announced that it will participate in the upcoming H.C....

AmpliTech to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

AmpliTech Group Announces Newly Released Passive Product Lines for RF Industry

Sep 6, 2023

New Passive Components Provide Exceptional Performance, Reliability, and Versatility and Complement Active LNA Product Line Additional New Product Announcements Expected by Year End 2023 HAUPPAUGE, NY, September 6, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks and a worldwide distributor of packages and lids for integrated circuit assembly, and...

Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

Sep 6, 2023

CEO Josh Riggs will be meeting with registered investors on September 11-12, 2023 IRVINE, CA, September 6, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that it will participate in the upcoming H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023, at the Lotte New York Palace Hotel. Josh Riggs, CEO of Oncocyte, will be meeting 1x1 with registered investors during the conference. The Company’s virtual presentation...

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

Aug 28, 2023

First digital-droplet PCR assay to receive coverage Expect initial revenue generation in Q1 2024 IRVINE, CA, August 28, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that Palmetto GBA, the Medicare Administrative Contractor for the Centers for Medicare & Medicaid Services (CMS), has issued a positive coverage decision for the Company’s VitaGraft Kidney™ diagnostic test, confirming that the test has met the criteria for coverage under MolDX:...

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

AmpliTech Group Named Finalist in Prestigious HIA-LI 29th Annual Business Achievement Awards

Aug 23, 2023

Finalists Represent Top Contenders for Long Island-based Business Awards; Winners will be Announced during HIA-LI Annual Business Achievement Awards, Thursday, September 21, 2023 HAUPPAUGE, NY, August 23, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a worldwide distributor of packages and lids for...

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

AmpliTech Reports Second Quarter 2023 Financial Results

Aug 14, 2023

Reports Sales of $4.1 million, $1.9 million Gross Profit, and Record Gross Margin of 47% Company Continues to Invest for Growth HAUPPAUGE, NY, August 14, 2023 - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, today announced financial...

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

Oncocyte Reports Second Quarter 2023 Financial Results

Aug 10, 2023

Conference Call on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, August 10, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today reported financial results for the second quarter of 2023, ended June 30, 2023. Second Quarter and Recent Highlights Transplant product launch on pace for Q4 early access. Manufacturing transfer process for 48-target universal assay began in June Expanding clinical utility for VitaGraft Kidney, a recent...

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

ONCOCYTE REGAINS COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS

Aug 9, 2023

IRVINE, CA, August 9, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that it has received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market ("Nasdaq") stating that the Company has regained compliance with the Nasdaq minimum bid price continued listing requirement and the matter is now closed. The Company was previously notified by Nasdaq on August 9, 2022 that it was not in compliance with the minimum bid price...

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

PaxMedica to Join Fireside Chat with PCG Advisory Following Positive Top Line Results from PAX-HAT-301 Study

Aug 8, 2023

PaxMedica to discuss significance of Phase 3 study results Interview to be webcast on Tuesday, August 15, 2023, at 10:30 am ET TARRYTOWN, NY, August 8, 2023 - PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (APT) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms, will join PCG Advisory for a Fireside Chat on Tuesday, August 15, 2023,...

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference

Aug 8, 2023

CEO Josh Riggs will be meeting with registered investors on Tuesday, August 15, 2023 IRVINE, CA, August 8, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, announced today that it will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference taking place on August 14-15th, 2023. Josh Riggs, CEO of Oncocyte, will be meeting 1x1 or in small groups with registered investors on Tuesday, August 15, 2023. Interested investors can register for...

Oncocyte’s VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage

Oncocyte To Announce Second Quarter 2023 Financial Results

Aug 3, 2023

Conference Call and Webcast on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, August 3, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, announced today that it will release its second quarter 2023 financial results on Thursday, August 10, 2023, prior to the U.S. market open. The company will host a conference call and webcast on Thursday, August 10, 2023, at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time to discuss its financial results and...